Prediction of Heart Failure Hospitalization or Death After TAVR
This prediction model effectively stratifies post-transcatheter aortic valve replacement patients by risk of death or HF readmission, supporting its use to guide clinical surveillance and clinical trial enrollment for adjunctive medical therapies aimed at mitigating this risk.
Authors
- Wayne Batchelor (ORCID: https://orcid.org/0000-0002-3016-1150)
- J. Lindenfeld
- Angela Lowenstern (ORCID: https://orcid.org/0000-0003-2626-9238)
- Thomas A. Treibel (ORCID: https://orcid.org/0000-0003-1560-7414)
- Andrzej S. Kosinski (ORCID: https://orcid.org/0000-0003-4151-5185)
- Bassim El‐Sabawi (ORCID: https://orcid.org/0000-0001-5252-4293)
- Pratik Manandhar (ORCID: https://orcid.org/0000-0002-8294-7147)
- Brian R. Lindman (ORCID: https://orcid.org/0000-0002-6879-5343)
- M. Dweck
- Sreekanth Vemulapalli (ORCID: https://orcid.org/0000-0003-1599-2957)
- Philippe Généreux
- Michael Mack
- Javed Butler
- Martin B. Leon
- Vinod H. Thourani
- Nimesh Desai
- David J. Cohen
Institutions
- Valve (United States) (US)
- Duke University (US)
- Columbia University Irving Medical Center (US)
- Hospital of the University of Pennsylvania (US)
- Trinity College London (GB)
- Flower Hospital (US)
- Morristown Medical Center (US)
- University of Mississippi (US)
- Clinical Research Institute (US)
- Cardiovascular Research Foundation (US)
- Alaska Heart and Vascular Institute (US)
- Baylor Scott & White Health (US)
- University College London (GB)
- Columbia University (US)
- Vanderbilt University Medical Center (US)
- University of Edinburgh (GB)
Publication Details
- Journal
- Circulation Cardiovascular Interventions
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1161/circinterventions.125.015398
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00